48 Blood-based peripheral T cell cytotoxicity assay in predicting response to immune checkpoint inhibitors: a US pilot study

MLA

Yali Li, et al. “48 Blood-Based Peripheral T Cell Cytotoxicity Assay in Predicting Response to Immune Checkpoint Inhibitors: A US Pilot Study.” Journal for ImmunoTherapy of Cancer, vol. 11, no. Suppl 1, Nov. 2023. EBSCOhost, https://doi.org/10.1136/jitc-2023-SITC2023.0048.

APA

Yali Li, Rajesh Nair, Shumei Kato, Suzanna Lee, Kota Iwahori, Jonathon Woo, Michele Baltay, Junichi Akatsuka, Srinath Sampath, Christian Schmedt, & Srihari Sampath. (2023). 48 Blood-based peripheral T cell cytotoxicity assay in predicting response to immune checkpoint inhibitors: a US pilot study. Journal for ImmunoTherapy of Cancer, 11(Suppl 1). https://doi.org/10.1136/jitc-2023-SITC2023.0048

Chicago

Yali Li, Rajesh Nair, Shumei Kato, Suzanna Lee, Kota Iwahori, Jonathon Woo, Michele Baltay, et al. 2023. “48 Blood-Based Peripheral T Cell Cytotoxicity Assay in Predicting Response to Immune Checkpoint Inhibitors: A US Pilot Study.” Journal for ImmunoTherapy of Cancer 11 (Suppl 1). doi:10.1136/jitc-2023-SITC2023.0048.